Literature DB >> 8880487

Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening.

M Buimer1, G J van Doornum, S Ching, P G Peerbooms, P K Plier, D Ram, H H Lee.   

Abstract

Ligase chain reaction (LCR)-based tests for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infections in men and women attending a sexually transmitted disease clinic were evaluated. LCR testing of urethral swab and urine specimens from men and cervical swab and urine specimens from women was compared with culture of male urethral swabs and female cervical and urethral swabs, respectively. An expanded "gold standard" was defined as a positive culture or at least one specimen confirmed to be positive by LCR testing. The prevalence of C. trachomatis infection as detected by cell culture was 7.0% among 614 men and 5.0% among 602 women. By LCR, these values increased to 11.4 and 9.9% with urethral swabs and urine, respectively, for men and 9.6 and 9.1% with cervical swabs and urine, respectively, for women. Relative to the expanded gold standard, the sensitivity of cell culture with male urethral swabs or female cervical swabs was 57.3 and 45.5%, respectively, compared with corresponding values of 93.3 and 87.9% for LCR. The sensitivity of LCR with urine specimens was 77.3 and 78.8% for men and women, respectively. The prevalence of N. gonorrhoeae infection as detected by culture was 5.9% among 220 men and 2.9% among 383 women. The corresponding values were 8.2 and 5.5%, respectively, by LCR testing of swabs. Prevalence values by LCR testing of urine were 7.3% for men and 2.9% for women. The sensitivity of culture was 72.2% for men and 50.0% for women. The sensitivities of LCR were 100% with male urethral swabs, 95.4% with female cervical swabs, 88.9% with male urine, and 50.0% with female urine. These results indicate that the LCR-based assays represent a major improvement in C. trachomatis and N. gonorrhoeae diagnostics. The sensitivity of testing of urethral or cervical swabs by LCR was markedly greater than that by culture. The sensitivity of testing female or male urine specimens was equal to or greater than that of culturing cervical or urethral specimens. LCR testing of urine specimens may prove useful for screening for C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880487      PMCID: PMC229278          DOI: 10.1128/jcm.34.10.2395-2400.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Variation and control of protein expression in Neisseria.

Authors:  T F Meyer; C P Gibbs; R Haas
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

2.  Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs.

Authors:  S Ching; H Lee; E W Hook; M R Jacobs; J Zenilman
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

3.  Amplification of Chlamydia trachomatis DNA by ligase chain reaction.

Authors:  B J Dille; C C Butzen; L G Birkenmeyer
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

4.  Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens.

Authors:  C A Bass; D L Jungkind; N S Silverman; J M Bondi
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

5.  Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction.

Authors:  M J Loeffelholz; C A Lewinski; S R Silver; A P Purohit; S A Herman; D A Buonagurio; E A Dragon
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

6.  Preliminary evaluation of the ligase chain reaction for specific detection of Neisseria gonorrhoeae.

Authors:  L Birkenmeyer; A S Armstrong
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

7.  Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine.

Authors:  J E Bauwens; A M Clark; M J Loeffelholz; S A Herman; W E Stamm
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

8.  Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay.

Authors:  J E Bauwens; A M Clark; W E Stamm
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

9.  Effects of broadening the gold standard on the performance of a chemiluminometric immunoassay to detect Chlamydia trachomatis antigens in centrifuged first void urine and urethral swab samples from men.

Authors:  D Jang; J W Sellors; J B Mahony; L Pickard; M A Chernesky
Journal:  Sex Transm Dis       Date:  1992 Nov-Dec       Impact factor: 2.830

10.  Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay.

Authors:  G Jaschek; C A Gaydos; L E Welsh; T C Quinn
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more
  39 in total

1.  Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  A M Gronowski; S Copper; D Baorto; P R Murray
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.

Authors:  L H Bachmann; I Lewis; R Allen; J R Schwebke; L C Leviton; H A Siegal; E W Hook
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Comparative evaluation of BDProbeTec ET, LCx and PACE 2 assays for the detection of Chlamydia trachomatis in urogenital specimens.

Authors:  C Pollara; L Terlenghi; M A De Francesco; F Gargiulo; F Perandin; N Manca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-18       Impact factor: 3.267

4.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests.

Authors:  E Van Dyck; M Ieven; S Pattyn; L Van Damme; M Laga
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 5.  Sexually transmitted infections.

Authors:  C Carne
Journal:  BMJ       Date:  1998-07-11

6.  Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women.

Authors:  Rebecca A Lillis; M Jacques Nsuami; Leann Myers; David H Martin
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

Review 7.  Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group.

Authors:  R Hayes; M Wawer; R Gray; J Whitworth; H Grosskurth; D Mabey
Journal:  Genitourin Med       Date:  1997-12

8.  Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population.

Authors:  K C Carroll; W E Aldeen; M Morrison; R Anderson; D Lee; S Mottice
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  High postpartum rates of sexually transmitted infections among teens: pregnancy as a window of opportunity for prevention.

Authors:  J R Ickovics; L M Niccolai; J B Lewis; T S Kershaw; K A Ethier
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

10.  External quality assessment program for Chlamydia trachomatis diagnostic testing by nucleic acid amplification assays.

Authors:  Sally Land; Sepehr Tabrizi; Anthony Gust; Elizabeth Johnson; Susan Garland; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.